Monthly Archives: September 2010

Drug Patent Expirations in September 2010

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
MUSE Vivus alprostadil 5,242,391 Sep 7, 2010
ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate RE40045 Sep 7, 2010
ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate RE40045 Sep 7, 2010
ZINECARD Pharmacia And Upjohn dexrazoxane hydrochloride 5,242,901 Sep 7, 2010
ADVAIR HFA Glaxosmithkline fluticasone propionate; salmeterol xinafoate RE40045 Sep 7, 2010
ADVAIR DISKUS 250/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate RE40045 Sep 7, 2010
DENAVIR Novartis penciclovir sodium 6,573,378 Sep 24, 2010
DENAVIR Novartis penciclovir sodium 5,075,445 Sep 24, 2010
NAROPIN App Pharms ropivacaine hydrochloride monohydrate 4,870,086 Sep 24, 2010
ACCOLATE Astrazeneca zafirlukast 4,859,692 Sep 26, 2010
ACCOLATE Astrazeneca zafirlukast 5,583,152 Sep 26, 2010
AGGRASTAT Medicure tirofiban hydrochloride 5,658,929 Sep 27, 2010
AGGRASTAT Medicure tirofiban hydrochloride 5,880,136 Sep 27, 2010
FERIDEX I.V. Amag Pharms Inc ferumoxides 5,248,492 Sep 28, 2010
IMODIUM MULTI-SYMPTOM RELIEF Mcneil loperamide hydrochloride; simethicone 5,612,054 Sep 28, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com